A researcher holds a vial of the ChAdOx1 coronavirus vaccine while a trial volunteer sits in the background
The Oxford COVID-19 vaccine trial was designed to test a new COVID-19 vaccine in health volunteers as well as to assess how well people across a broad age range could be protected from COVID-19 with this new vaccine.

Oxford University breakthrough on global COVID-19 vaccine

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Read the full article on the Oxford University news page.